Invesco Ltd.

Position in LCTX — Lineage Cell Therapeutics, Inc.

CIK 914208 Atlanta, GA

Position in LCTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$131,168

+$105,052 QoQ

Shares Held

100,129

+72.5% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#38

of 130 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 0% Shared 95% None 5%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. LCTX ranks #264 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$131,168	100,129	+72.5%	Shares	Defined	2026-08-14
2025-03-31	$26,116	58,038	-6.1%	Shares	Defined	2025-05-12
2024-12-31	$30,892	61,785	+2.1%	Shares	Defined	2025-02-13
2024-09-30	$55,065	60,513	+6.6%	Shares	Defined	2024-11-12
2024-06-30	$56,764	56,764	+0.0%	Shares	Defined	2024-08-13
2024-03-31	$83,988	56,749	-0.2%	Shares	Defined	2024-05-14
2023-12-31	$61,997	56,879	-13.7%	Shares	Defined	2024-02-13
2023-09-30	$77,751	65,892	0.0%	Shares	Defined	2023-11-13
2023-06-30	$92,907	65,892	+90.9%	Shares	Defined	2023-08-11
2022-03-31	$53,157	34,518	-18.4%	Shares	Defined	2022-05-16
2021-12-31	$103,592	42,283	-24.0%	Shares	Defined	2022-02-14
2021-09-30	$140,220	55,643	+25.2%	Shares	Defined	2021-11-15
2021-06-30	$126,673	44,447	—	Shares	Defined	2021-08-17
No filing history on record for this holder in this stock.